Dr Hersh Vivek Goel, MD in Tucson, AZ - General Practice

Dr Hersh Vivek Goel, MD is a General Practice physician based in Tucson, Arizona. Dr Hersh Vivek Goel is licensed to practice in Arizona (license number 53576) and his current practice location is 90 W River Rd, Tucson, Arizona. He can be reached at his office (for appointments etc.) via phone at (520) 302-5096.

NPI number for Dr Hersh Vivek Goel is 1477940609 and his current mailing address is 3662 W Ina Rd, Suite 150, Tucson, Arizona. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1477940609.

Contact Information

	Dr Hersh Vivek Goel, MD
	90 W River Rd, Tucson, AZ 85704-5130
	(520) 302-5096
	Not Available

Physician's Profile

Full Name	Dr Hersh Vivek Goel
Gender	Male
Speciality	General Practice
Location	90 W River Rd, Tucson, Arizona
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1477940609
Provider Enumeration Date: 04/26/2015
Last Update Date: 02/15/2017

Medical Identifiers

Medical identifiers for Dr Hersh Vivek Goel such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477940609	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	53576 (Arizona)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Hersh Vivek Goel is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Hersh Vivek Goel, MD 3662 W Ina Rd, Suite 150, Tucson, AZ 85741-2269 Ph: (520) 302-5096	Dr Hersh Vivek Goel, MD 90 W River Rd, Tucson, AZ 85704-5130 Ph: (520) 302-5096

News Archive

UTHealth student receives UNCF/Merck fellowship for multidrug-resistant CDI research

Charles Darkoh, a graduate student at The University of Texas Health Science Center at Houston (UTHealth), has been awarded a fellowship from the United Negro College Fund (UNCF) and Merck for his research into a major health problem - multidrug-resistant Clostridium difficile bacterial infection.

Conference examines lagging ethical guidelines in face of expanding clinical trials in developing countries

SciDev.Net reports on the 7th World Conference of Science Journalists, taking place this week in Qatar, where participants discussed how the number of clinical trials in developing countries is surging despite legal and ethical frameworks often not being in place.

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

Women who eat more high-fiber foods during young adulthood may have lower breast cancer risk

Women who eat more high-fiber foods during adolescence and young adulthood-especially lots of fruits and vegetables-may have significantly lower breast cancer risk than those who eat less dietary fiber when young, according to a new large-scale study led by researchers at Harvard T.H. Chan School of Public Health.

General Practice Doctors in Tucson, AZ

Samuel Philbrick, MD General Practice Medicare: Medicare Enrolled Practice Location: 655 N Alvernon Way, Tucson, AZ 85711 Phone: 520-792-1450
Dr. Yvonne Annette Skinner, N.M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2016 S 4th Ave, Tucson, AZ 85713 Phone: 520-882-4252 Fax: 520-792-2835
Dr. Brian Lloyd Cabin, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 772n Country Club Rd, Tucson, AZ 85716 Phone: 520-319-2810 Fax: 520-319-2814
Alexander Peter Cadoux, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2870 E Skyline Dr Ste 100, Tucson, AZ 85718 Phone: 520-529-9665 Fax: 520-529-9669
Lacey Brooke Mastroberte-padd, DVM General Practice Medicare: Not Enrolled in Medicare Practice Location: 6464 N Oracle Rd, Tucson, AZ 85704 Phone: 520-829-5166
Dr. Leah Marie Schmidt, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 1925 W Orange Grove Rd, Suite 303, Tucson, AZ 85704 Phone: 520-219-6394 Fax: 520-219-6398
Dr. Derek Frazier, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 3390 N Campbell Ave, Suite 110, Tucson, AZ 85719 Phone: 520-795-7650 Fax: 520-325-1622

Dr Hersh Vivek Goel, MD - General Practice in Tucson, AZ